(Q33964958)

30 July 2017

1 reference

title

Bradykinin and the pathophysiology of angioedema (English)

1 reference

30 July 2017

1 reference

Marco Cicardi

3

0 references

Massimo Cugno

object named as

Massimo Cugno

series ordinal

1

0 references

author name string

Jürg Nussberger

series ordinal

2

1 reference

PubMed ID

12639808

30 July 2017

Angelo Agostoni

series ordinal

4

1 reference

30 July 2017

1 March 2003

1 reference

International Immunopharmacology

30 July 2017

1 reference

30 July 2017

3

1 reference

30 July 2017

3

1 reference

30 July 2017

311-317

1 reference

Appraisal of the validity of histamine-induced wheal and flare to predict the clinical efficacy of antihistamines

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Drug-induced angioedema without urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Vasopeptidase inhibition and angio-oedema

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Idiopathic nonhistaminergic angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

C1 inhibitor and hereditary angioneurotic edema

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Hereditary angioneurotic edema. II. Deficiency of inhibitor for serum globulin permeability factor and/or plasma kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Elevated plasmin-alpha 2-antiplasmin complex levels in hereditary angioedema: evidence for the in vivo efficiency of the intrinsic fibrinolytic system

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Detection of active kallikrein in induced blister fluids of hereditary angioedema patients

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of “spontaneous” formation of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: A rationale for prophylactic use of tranexamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Examination of baseline levels of carboxypeptidase N and complement components as potential predictors of angioedema associated with the use of an angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Plasma bradykinin in angio-oedema.

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Plasma kinins increase after angiotensin-converting enzyme inhibition in human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Bradykinin-mediated angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Local bradykinin generation in hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

Angioedema due to angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1567-5769%2802%2900162-5

7 January 2021

10.1016/S1567-5769(02)00162-5

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

12639808